Clinical Trials Logo

Clinical Trial Summary

This study evaluates plaque progression and characteristics in patients with coronary atherosclerosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05800093
Study type Observational
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Erik SG Stroes, MD PhD
Phone +31205669111
Email e.s.stroes@amsterdamumc.nl
Status Recruiting
Phase
Start date January 12, 2023
Completion date December 1, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05462262 - Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population N/A
Not yet recruiting NCT06040073 - Natural History of Coronary Atherosclerosis
Active, not recruiting NCT03349385 - Registry of Secondary Revascularization
Recruiting NCT05860400 - Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Completed NCT03540381 - Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization
Recruiting NCT05783804 - Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
Completed NCT03192579 - Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial Phase 4
Completed NCT03195621 - Critical Treatment of Coronary Artery Disease N/A
Recruiting NCT03533959 - To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy
Recruiting NCT04772768 - Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
Not yet recruiting NCT06007248 - Disease Characteristics of IR-CAD: a Case-control Study
Recruiting NCT03943459 - Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease Phase 3
Recruiting NCT03788369 - Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization